Investing.com - Jasper Therapeutics (NASDAQ: JSPR) reported third quarter EPS of $-0.160, worse than the analyst estimate of $-0.155. Revenue for the quarter came in at $0.00 versus the...
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell...
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell...
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address diseases...
Investing.com - Jasper Therapeutics (NASDAQ: JSPR) reported second quarter EPS of $-0.150, in line with the analyst estimate of $-0.150. Revenue for the quarter came in at $0.00 versus the...
An analyst from CapitalOne initiated coverage of Jasper Therapeutics (NASDAQ: JSPR) at 'overweight' with a price target of $7.00. Prior to this rating, Jasper Therapeutics had 5 buy...
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address diseases such as...
Investing.com - Jasper Therapeutics (NASDAQ: JSPR) reported first quarter EPS of $-0.160, in line with the analyst estimate of $-0.160. Revenue for the quarter came in at $0.00 versus the...
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address diseases such as...
Jasper Therapeutics (JSPR) has filed $250,000,000 mixed shelf of:Common Stock Preferred Stock Debt Securities Warrants Rights Units Depositary...
Investing.com - Jasper Therapeutics (NASDAQ: JSPR) reported first quarter EPS of $-0.360, $0.01 better than the analyst estimate of $-0.374. Revenue for the quarter came in at $0.00 versus...
Jasper Therapeutics, Inc. (JSPR) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33).
Investing.com - Jasper Therapeutics reported on Thursday third quarter {{erl-1163569||earnings that beat analysts' forecasts and revenue that was inline with expectations. Jasper...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
By Sam Boughedda Investing.com — U.S. stock indices closed mostly higher Wednesday after a rally in tech stocks. Here are some of the most significant winners today: Jasper Therapeutics...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Utilities, Basic Materials and Technology sectors propelled shares higher while losses in the Financials,...
By Sam Boughedda Investing.com — Shares of biotechnology firm Jasper Therapeutics (NASDAQ:JSPR) soared 112% after Oppenheimer analyst Jay Olson initiated coverage of the company with a...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Utilities, Healthcare and Consumer Goods sectors propelled shares higher while losses in the Basic...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Oil & Gas, Financials and Industrials sectors propelled shares higher. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
